Zobrazeno 1 - 10
of 154
pro vyhledávání: '"LIANGMING ZHANG"'
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Purpose Both vitamin C and D deficiencies are extremely common in clinical practice, especially in elderly population. Unfortunately, the role of vitamin C deficiency in osteoporosis related consequences is often neglected. The aim of the pr
Externí odkaz:
https://doaj.org/article/b014c4e02dcf4b6ba1a2ed7343ffc30c
Autor:
Yubao Lu, Zhizhong Shang, Wei Zhang, Mao Pang, Xuchang Hu, Yu Dai, Ruoqi Shen, Yingjie Wu, Chenrui Liu, Ting Luo, Xin Wang, Bin Liu, Liangming Zhang, Limin Rong
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background This study employs systematic review and meta-analysis to explore the incidence and characteristics of spinal cord injury (SCI) between 2000 and 2021, aiming to provide the most recent and comprehensive data support for the preven
Externí odkaz:
https://doaj.org/article/7f77da78f52042c48b11afd05071153e
Autor:
Yang Yang, Bin Liu, Ting Luo, Lei He, Limin Rong, Zizhao Wu, Mao Pang, Ruiqiang Chen, Peigen Xie, Bu Yang, Zifang Huang, Shangfu Li, Jianwen Dong, Liangming Zhang
Publikováno v:
BMJ Open, Vol 14, Iss 9 (2024)
Introduction Degenerative lumbar spinal stenosis is a common cause of low back or leg pain and disability in the elderly population. Patients with spinal stenosis who fail to respond to conservative treatment often require surgical interventions. Min
Externí odkaz:
https://doaj.org/article/e769b989faa24d129165b7410c39a18a
Autor:
Guangming Mao, Wenhao Xu, Lingli Wan, Hongpin Wang, Shutao Xu, Liangming Zhang, Shiyang Li, Jifa Zhang, Zhongming Lai, Yuping Lan, Jianhui Liu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundType 2 Diabetes Mellitus (T2D) and Osteoarthritis (OA) are both prevalent diseases that significantly impact the health of patients. Increasing evidence suggests that there is a big correlation between T2D and OA, but the molecular mechanis
Externí odkaz:
https://doaj.org/article/20708901e2214782b8de83c14a6860c3
Autor:
KUN YANG, BINGSUO MA, TING YU, KEXIN LI, LIANGMING ZHANG, XIAOYAN YUAN, HAIZHU ZHANG, ZIJUN YAN YAN, TONG CHEN
Publikováno v:
Acta Poloniae Pharmaceutica, Vol 81, Iss 1, Pp 13-33 (2024)
Exosomes are extracellular vesicles naturally released from cells. Exosomes from different sources play different roles in cellular component exchange, signal transduction, and pathological development. Exosomes have distinct biological characteristi
Externí odkaz:
https://doaj.org/article/6230402616c847d49f951f7323edd424
Autor:
Liangming Zhang, Xiongfeng Chen, Jianwei Wang, Meihong Chen, Juan Chen, Wanzhen Zhuang, Yu Xia, Zhixin Huang, Yue Zheng, Yi Huang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Cysteine protease inhibitor 1 (CST1) is a cystatin superfamily protein that inhibits cysteine protease activity and is reported to be involved in the development of many malignancies. Mitochondrial oxidative phosphorylation (OXPHOS) also pla
Externí odkaz:
https://doaj.org/article/77e5bc931213410190d160d2d1321dab
Publikováno v:
Asian Spine Journal, Vol 18, Iss 1, Pp 21-31 (2024)
Study Design A retrospective cohort study. Purpose To analyze the association between preoperative adjacent facet joint osteoarthritis (FJOA) and outcomes of lumbar interbody fusion (LIF). Overview of Literature Whether preoperative adjacent FJOA is
Externí odkaz:
https://doaj.org/article/bc7fb291a6e1427ca00a7ad118c97a41
Autor:
Wenhui Zhong, Yunliang Liu, Liangming Zhang, Wanzhen Zhuang, Jianlin Chen, Zhixin Huang, Yue Zheng, Yi Huang
Publikováno v:
PeerJ, Vol 11, p e16424 (2023)
Purpose Optimal serological biomarkers have been absent for the early diagnosis of endometrial cancer, to date. In this study, we aimed to define the diagnostic performances of individual and combined detection of serum cysteine protease inhibitor 1
Externí odkaz:
https://doaj.org/article/7a43314a07f84316b3ff43f2ee44fa81
Autor:
Yuankai Shi, Jianhua Chen, Helong Zhang, Zhihong Zhang, Yiping Zhang, Zhehai Wang, Shucai Zhang, Jian Zhao, Chunling Liu, Xiuwen Wang, Yanqiu Zhao, Changlu Hu, Lei Yang, Xuezhi Hao, Lin Wang, Yunpeng Liu, Yan Yu, Jun Zhao, Mengzhao Wang, Liangming Zhang, Sanyuan Sun, Yanping Hu, Kangsheng Gu, Xiaosheng Hang, Jinlu Shan, Yu Zhang, Bangxian Tan, Weihua Yang, Runxiang Yang, Meimei Si, Huaize Geng, Hui Li, Xiaoyan Kang
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background Iruplinalkib (WX-0593) is an anaplastic lymphoma kinase (ALK)/c-ros oncogene 1 (ROS1) tyrosine kinase inhibitor. Here we reported the single-arm, phase II study (INTELLECT) results of the efficacy and safety of iruplinalkib for AL
Externí odkaz:
https://doaj.org/article/fa1f8545777d42219ff4b4af29402825
Autor:
Yuankai Shi, Jianying Zhou, Yanqiu Zhao, Bo Zhu, Liangming Zhang, Xingya Li, Jian Fang, Jianhua Shi, Zhixiang Zhuang, Sheng Yang, Donglin Wang, Huiqing Yu, Longzhen Zhang, Rongsheng Zheng, Michael Greco, Tingting Wang
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Rezivertinib (BPI-7711) is a novel third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). This phase IIa study was part of a phase I/IIa study (NCT03386955), aimed to evaluate the efficacy and sa
Externí odkaz:
https://doaj.org/article/1a68837f5b334a76b6788911530e9531